Company: ARAI
Filing Date: 2025-07-15
Form Type: S-1/A
Source: 0001641172-25-019572
Chunk: 121

Company: Arrive AI Inc.
Filing Date: 2025-07-15
Form: S-1/A
Chunk 121
---
 University and a BSc from the London
School of Economics. His expertise in navigating complex operational landscapes and data-driven decision-making makes him an invaluable
asset for a public company aiming to scale sustainably on NASDAQ.

John Ritchison, JD – Director, Corporate Counsel

John Ritchison serves as Director and Corporate
Counsel at Arrive AI Inc., contributing his extensive expertise in engineering, patent law, and global operations to support the company’s
strategic initiatives. Since the company’s incorporation as Dronedek Inc. in 2020, John has served as Corporate Counsel while simultaneously
maintaining his solo practice in Intellectual Property law, which he has operated for over 22 years. As a registered patent attorney
and Indiana-licensed professional engineer, John brings valuable legal and technical insights to Arrive AI’s preparations for a
NASDAQ listing. John’s 30-year career with Delphi and General Motors included senior roles in manufacturing and product engineering,
with responsibilities spanning U.S. and international markets. His leadership experience includes roles as a plant manager in the U.S.
and as General Director of Operations in Europe, where he managed full P&L and balance sheet responsibilities. His extensive experience
in manufacturing, engineering, and operations enhances Arrive AI’s approach to scaling and compliance in the autonomous systems
industry. John’s academic background includes a JD from Indiana University School of Law, a master’s in mechanical engineering
from Rose-Hulman, and a bachelor’s in mathematics. Fluent in English and Portuguese, he is also admitted to practice before the
U.S. Supreme Court. John’s blend of legal, technical, and global business experience strengthens Arrive AI’s positioning
for sustainable growth on NASDAQ.

John Gallina – Director

John Gallina is the chairman of the Audit and
Finance committee and has over 40 years of financial and business management in both a Corporate and Public Accounting environment. John
most recently served as Executive Vice President and Chief Financial Officer for Elevance Health, one of the nation’s leading health
benefits companies serving 47.5 million members within its family of health plans and representing more than $170 billion in annual revenues,
ranked #20 on the Fortune 500 list. He held several executive positions in his nearly 30 years at Elevance Health, including Chief Accounting
Officer and Senior Vice President of Internal Audit and Continuous Improvement. He was also a member of the Anthem Initial Public Offering
team and was instrumental in the due diligence and integration of Anthem’s acquisitions.

Kevin